Asceniv

Product manufactured by Adma Biologics, Inc.

Application Nr Approved Date Route Status External Links
BLA125590 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Asceniv (Immune Globulin Intravenous, Human – Slra) Is A 10% Immune Globulin Liquid For Intravenous Injection, Indicated For The Treatment Of Primary Humoral Immunodeficiency (Pi) In Adults And Adolescents (12 To 17 Years Of Age). Pi Includes, But Is Not Limited To, The Humoral Immune Defect In Congenital Agammaglobulinemia, Common Variable Immunodeficiency (Cvid), X-Linked Agammaglobulinemia, Wiskott-Aldrich Syndrome, And Severe Combined Immunodeficiencies (Scid). Asceniv (Immune Globulin Intravenous, Human – Slra) Is A 10% Immune Globulin Liquid For Intravenous Injection, Indicated For The Treatment Of Primary Humoral Immunodeficiency (Pi) In Adults And Adolescents (12 To 17 Years Of Age). [1]

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Human Immunoglobulin G

Comments